Can we predict the influence of inflammation on voriconazole exposure? An overview - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Journal of Antimicrobial Chemotherapy Année : 2023

Can we predict the influence of inflammation on voriconazole exposure? An overview

Résumé

Voriconazole is a triazole antifungal indicated for invasive fungal infections that exhibits a high degree of inter-individual and intra-individual pharmacokinetic variability. Voriconazole pharmacokinetics is non-linear, making dosage adjustments more difficult. Therapeutic drug monitoring is recommended by measurement of minimum plasma concentrations. Several factors are responsible for the high pharmacokinetic variability of voriconazole: age, feeding (which decreases absorption), liver function, genetic polymorphism of the CYP2C19 gene, drug interactions and inflammation. Invasive fungal infections are indeed very frequently associated with inflammation, which engenders a risk of voriconazole overexposure. Many studies have reviewed this topic in both the adult and paediatric populations, but few studies have focused on the specific point of the prediction, to evaluate the influence of inflammation on voriconazole pharmacokinetics. Predicting the impact of inflammation on voriconazole pharmacokinetics could help optimize antifungal therapy and improve patient management. This review summarizes the existing data on the influence of inflammation on voriconazole pharmacokinetics in adult populations. We also evaluate the role of C-reactive protein, the impact of inflammation on patient metabolic phenotypes, and the tools that can be used to predict the effect of inflammation on voriconazole pharmacokinetics.
Fichier principal
Vignette du fichier
OGLIONE-KERRIEN et al-2023-Can we predict the influence of inflammation on voriconazole exposure An.pdf (1.26 Mo) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Licence : CC BY NC - Paternité - Pas d'utilisation commerciale

Dates et versions

hal-04264817 , version 1 (11-12-2023)

Identifiants

Citer

Christelle Boglione-Kerrien, Sélim Zerrouki, Audrey Le Bot, Christophe Camus, Tony Marchand, et al.. Can we predict the influence of inflammation on voriconazole exposure? An overview. Journal of Antimicrobial Chemotherapy, 2023, 78 (11), pp.2630-2636. ⟨10.1093/jac/dkad293⟩. ⟨hal-04264817⟩
33 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More